on the basis of the intended mode of administration for example when considering the oral mode of administration the bl p 2013 compound can be used in the form of tablets capsules lozenges troches powders syrups elixirs aqueous solutions and the like in accordance with standard pharmaceutical practice the proportional ratio of active ingredients to carrier will naturally depend on the chemical nature solubility stability and potency of the active ingredients as well as the dosage contemplated however these pharmaceutical compositions will likely contain from about 5 to about 80 of carrier in the case of tablets for oral use carriers which are commonly used include lactose sodium citrate and salts of phosphoric acid various disintegrants such as starch and lubricating agents such as magnesium stearate sodium lauryl sulfate and talc are commonly used in tablets for oral administration in capsule form useful diluents are lactose and high molecular weight polyethylene glycols when aqueous suspensions are required for oral use the active ingredients are combined with emulsifying and suspending agents if desired certain sweetening and or flavoring agents can be added for parenteral administration which includes intramuscular intraperitoneal subcutaneous and intravenous use sterile solutions of the active ingredients are usually prepared and the ph of the solutions are suitably adjusted and buffered for intravenous use the total concentration of solutes should be preferably controlled to render the preparation substantially isotonic the prescribing physician will decide the dosage to be used in a human subject including the ratio of the dosage weight of bl p 2013 compound and.